Observations placeholder
Ursodiol and Urso 250
Identifier
020335
Type of Spiritual Experience
Background
A description of the experience
Ursodeoxycholic acid (INN, BAN and AAN), also known as ursodiol (USAN) and the abbreviation UDCA, from the root-word for bear urso, as bear bile contains the substance, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria.
Ursodiol is the only FDA approved drug to treat primary biliary cirrhosis. Ursodiol may be used for biliary stasis in pregnant women to relieve the symptoms of itching and decrease bile absorption
Primary bile acids are produced by the liver and stored in the gall bladder. When secreted into the intestine, primary bile acids can be metabolized into secondary bile acids by intestinal bacteria. Primary and secondary bile acids help the body digest fats. Ursodeoxycholic acid helps regulate cholesterol by reducing the rate at which the intestine absorbs cholesterol molecules while breaking up micelles containing cholesterol. Because of this property, ursodeoxycholic acid is used to treat (cholesterol) gallstones non-surgically. It is also used to relieve itching in pregnancy for some women who suffer obstetric cholestasis.
Ursodeoxycholic acid has also been shown experimentally to suppress immune response such as immune cell phagocytosis. Prolonged exposure and/or increased quantities of systemic (throughout the body, not just in the digestive system) ursodeoxycholic acid can be toxic.
A Cochrane review looking at primary biliary cirrhosis found that although ursodeoxycholic acid showed a reduction in liver biochemistry, jaundice, and ascites, it did not decrease mortality or liver transplantation.
On Jan, 13, 2017 5,019 people reported to have side effects when taking Urso 250.
Among them, 15 people (0.3%) have Hallucination
On Dec, 26, 2016,1,984 people reported to have side effects when taking Ursodeoxycholic Acid. Among them, 2 people (0.1%) have Hallucination
On Dec, 23, 2016 4,557 people reported to have side effects when taking Ursodiol.
Among them, 14 people (0.31%) have Hallucination
Time on Ursodiol when people have Hallucination :
| n/a |
Gender of people who have Hallucination when taking Ursodiol :
| Female | Male | |
| Hallucination | 42.86% | 57.14% |
Age of people who have Hallucination when taking Ursodiol :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 14.29% | 28.57% | 0.00% | 0.00% | 14.29% | 42.86% | 0.00% |
Severity of Hallucination when taking Ursodiol :
| n/a |
How people recovered from Hallucination :
| n/a |
Top conditions involved for these people :
- Depression (1 people, 14.29%)
- Adenovirus infection (1 people, 14.29%)
- Insomnia (1 people, 14.29%)
On Jan, 28, 2016: 3,369 people reported to have side effects when taking Ursodiol. Among them, 46 people (1.37%) have Death.
Time on Ursodiol when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 25.00% | 50.00% | 0.00% | 25.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Ursodiol :
| Female | Male | |
| Death | 46.67% | 53.33% |
Age of people who have Death when taking Ursodiol :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 6.45% | 3.23% | 3.23% | 0.00% | 22.58% | 64.52% |
Top conditions involved for these people :
- Hypertension (5 people, 10.87%)
- Hyperlipidaemia (3 people, 6.52%)